Tianjin Chase Sun Pharmaceutical Co.,Ltd (SHE:300026)
China flag China · Delayed Price · Currency is CNY
3.590
+0.010 (0.28%)
Mar 10, 2026, 10:19 AM CST

Tianjin Chase Sun Pharmaceutical Co.,Ltd Company Description

Tianjin Chase Sun Pharmaceutical Co.,Ltd engages in the research and development, production, and sale of various pharmaceutical products in China and internationally.

The company provides Chinese medicine formula granules, finished drugs, raw materials, medical devices and excipients, medical and health services, as well as smart supply chain for pharmaceuticals and medical devices.

It serves the fields of immunity, cardiovascular and cerebrovascular diseases, respiratory system, and neurodegenerative diseases.

The company was founded in 1996 and is headquartered in Tianjin, China.

Tianjin Chase Sun Pharmaceutical Co.,Ltd
Country China
Founded 1996
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 5,297
CEO Wu Jun Lan

Contact Details

Address:
Building B01, Entrepreneurial Headquarters Base
Tianjin, 301700
China
Phone 86 22 5962 3160
Website chasesun.cn

Stock Details

Ticker Symbol 300026
Exchange Shenzhen Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
ISIN Number CNE100000GF1
SIC Code 2836

Key Executives

Name Position
Wu Jun Lan Vice Chairman and GM
Wu Sun Executive Vice President, Chief Financial Officer, Chief Accountant and Director
Rui Qiang Chen Deputy General Manager
Chun Xu Li Deputy GM and Director
Yi Yang Secretary of the Board of Directors
Kun Zhang Deputy General Manager
Xiao Zhong Lu Deputy General Manager